The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,774.00
Ask: 1,774.50
Change: -10.50 (-0.59%)
Spread: 0.50 (0.028%)
Open: 1,796.00
High: 1,808.50
Low: 1,772.50
Prev. Close: 1,788.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Stocks surge as markets play catch up after long weekend

Tue, 28th May 2013 08:30

UK markets surged in early trading on Tuesday with traders wasting no time in playing catch up as they returned to their desks following the three-day weekend.After reaching a 13-year high on Wednesday, the FTSE 100 dropped sharply in the latter part of last week on fears of a scaling back of stimulus measures from the US Federal Reserve - after comments from Fed Chairman Ben Bernanke - as well as some gloomy economic data from China.However, Senior Market Analyst Michael Hewson from CMC Markets said that stocks were expected to make up for lost ground today following a fairly quiet but positive European session yesterday.Ahead of the open, Hewson said: "The extra day for UK and US markets is likely to have been useful for investors to weigh up and absorb last week's events, and what they mean going forward for their asset allocation decisions in a world where the prospect of open ended quantitative easing from the US is no longer the done deal investors thought it was a few weeks ago, while a Chinese slowdown remains a growing concern."The economic data calendar is looking pretty light for Tuesday with no major releases due out in Europe this morning, though eyes will be fixed on consumer confidence and home-price figures in the States due out this afternoon.Pharmas gains early onDrugs giant AstraZeneca was among the high risers this morning after saying that it will continue to "vigorously" defend the intellectual property rights protecting its asthma medicine Pulmicort Respules. The company is appealing against a US court ruling that the patent protecting Pulmicort from rival drugs in the US is invalid. Sector peers Shire and GlaxoSmithKline were also in demand early on, with the latter being boosted by an upgrade by Deutsche Bank to 'buy'. The broker also lifted its target price for the shares from 1,620p to 1,930p.Wood Group was also higher on news that its PSN business will continue to provide duty holder and asset management services to the Hummingbird Spirit floating storage offloading production vessel, under a new contract extension worth $87m from Teekay. Positive comments from Bank of America Merrill Lynch were helping share prices of a number of retailers this morning after the broker raised its target prices for Sainsbury, Marks & Spencer, Tesco, Dixons, SuperGroup and Darty.Financial stocks were also performing well as markets on the whole rebounded from last week's sell-off. HSBC, Barclays and Standard Chartered were in positive territory, joined by part-nationalised lenders RBS and Lloyds which were both shrugging off downgrades by Citigroup today.Polymer manufacturer Victrex was a high riser on the FTSE 250 after increasing its interim dividend by 15% and beating profit forecasts by 2.0% in the first half.Soft drinks maker AG Barr was also up as it managed to increase revenues by 2.4% in the first quarter in spite of the dismal weather.FTSE 100 - RisersTUI Travel (TT.) 371.60p +3.65%GKN (GKN) 305.00p +2.90%Hargreaves Lansdown (HL.) 1,017.00p +2.83%International Consolidated Airlines Group SA (CDI) (IAG) 280.50p +2.75%Petrofac Ltd. (PFC) 1,376.00p +2.69%easyJet (EZJ) 1,283.00p +2.64%GlaxoSmithKline (GSK) 1,795.50p +2.63%Barclays (BARC) 325.15p +2.57%IMI (IMI) 1,341.00p +2.44%Weir Group (WEIR) 2,349.00p +2.35%FTSE 100 - FallersEurasian Natural Resources Corp. (ENRC) 249.40p -2.12%Randgold Resources Ltd. (RRS) 4,941.00p -0.94%Rio Tinto (RIO) 2,850.50p -0.58%Glencore Xstrata (GLEN) 330.55p -0.39%Severn Trent (SVT) 2,070.00p -0.05%Anglo American (AAL) 1,556.00p -0.03%FTSE 250 - RisersNew World Resources A Shares (NWR) 114.00p +7.75%Victrex (VCT) 1,739.00p +6.82%Ocado Group (OCDO) 272.70p +3.49%Spirax-Sarco Engineering (SPX) 2,880.00p +3.34%888 Holdings (888) 165.20p +3.12%Mitchells & Butlers (MAB) 396.50p +2.96%Ferrexpo (FXPO) 175.40p +2.93%Berkeley Group Holdings (The) (BKG) 2,183.00p +2.83%Inchcape (INCH) 564.00p +2.73%Pace (PIC) 256.70p +2.68%FTSE 250 - FallersDunelm Group (DNLM) 860.00p -1.15%Carpetright (CPR) 635.00p -1.01%Menzies(John) (MNZS) 711.00p -0.97%Telecom Plus (TEP) 1,275.00p -0.93%TalkTalk Telecom Group (TALK) 228.00p -0.87%Investec (INVP) 480.40p -0.87%Kenmare Resources (KMR) 31.40p -0.82%BH Global Ltd. GBP Shares (BHGG) 1,244.00p -0.64%Ted Baker (TED) 1,481.00p -0.60%John Laing Infrastructure Fund Ltd (JLIF) 113.50p -0.44%
More News
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more
17 May 2024 08:39

GSK raises $1.5 bln from sale of remaining Haleon stake

May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more
17 May 2024 07:29

GSK raises £1.25bn from sale of remaining Haleon stake

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

Read more
16 May 2024 17:33

FTSE 100 ends lower on disappointing corporate updates, BT Group soars

BT Group up after CEO aims for more than double free cash flow

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.